MNKD trade ideas
MNKD Trend continuation, possible bullish outlook as long as price can stay above channel.
MNKD (with partner Sanofi) is about to market and distribute FDA approved Afrezza, a inhaled insulin that can make insulin syringes a thing of the past. With diabetes a global condition that effects 371 million people worldwide and is expected to affect 552 million by 2030, MNKD is the only FDA approved product of this kind.
Heavy short interest, proprietary technologyNow looks like a smart time to be investing in MNKD. Not only is Afrezza a better insulin than many available, not only does the technosphere eliminate a lot of potential unnecessary needles... the technosphere is the potential gold mine here. Imagine the FLU SHOT being a thing of the past... for the new, improved delivery system of a FLU INHALER. FDA can fast track drugs thru using technosphere... its already FDA approved. Many cultures in the world wont even USE a needle. Not to mention, HUGE SHORT INTEREST... once this sets fire, its gonna blaze...
$MNKD Current Technical Pattern Along with Support & ResistanceAlthough at the time of making these annotations MNKD is gapping-up in the premarket, the fact of the matter is this chart has been in a nasty downtrend and has formed a Bear Pennant Pattern. If it does gain any upside strength, the true test will come if the price can make it up to the pivotal $8 level. Until any multi-day closes above $8, I will remain bearish.
Another Man-delbrot on Mann-KindNow, on a daily basis we saw a self repeating analogy on MNKD
Then, todays rally on 2x avg vol suggested a closer look.
The amazing thing is that even on the weekly timeframe, we can see something:
the 2009-2011 price action might explain the entire chart from the same IPO, as we are now about to enter in the last stage of the analogy.
Definitely to be seen as a best case scenario.